Revvity (RVTY) Total Current Liabilities (2010 - 2026)
Revvity's (RVTY) quarterly Total Current Liabilities came in at $1.2 billion in Q2 2026, up 91.09% YoY from $648.2 million in Q2 2025, and down 6.96% on a QoQ basis from $1.3 billion in Q4 2025.
Revvity (RVTY) Total Current Liabilities (2010 - 2026) Analysis & Trends
Revvity (RVTY) has 17 years of Total Current Liabilities data on file, last reported at $1.2 billion in Q2 2026.
- Quarterly Total Current Liabilities rose 91.09% year-over-year to $1.2 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.2 billion (up 91.09% YoY) and the FY2025 annual result came in at $1.3 billion, up 103.83% from the prior year.
- Total Current Liabilities eased to $1.2 billion in Q2 2026, from $1.3 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.6 billion in Q2 2023 to a low of $648.2 million in Q1 2025.
- A 5-year average of $1.2 billion and a median of $1.3 billion in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities plunged 54.97% — and 2025, when it surged 103.83%.
- Tracing RVTY's Total Current Liabilities over 5 years: stood at $1.5 billion in 2022, then decreased by 2.37% to $1.5 billion in 2023, then sank by 54.97% to $653.1 million in 2024, then soared by 103.83% to $1.3 billion in 2025, then retreated by 6.96% to $1.2 billion in 2026.
- The last three Total Current Liabilities figures came in at $1.2 billion (Q2 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 1.29 Bn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 2.27 Bn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 8.82 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 558.26 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 1.58 Bn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 1.20 Bn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 1.79 Bn |
| 10 | Revvity | 12.78 Bn | 11.92 Bn | 387.66 Mn | 1.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 1.24 Bn |
| Dec 28, 2025 | 1.33 Bn |
| Sep 28, 2025 | 1.22 Bn |
| Jun 29, 2025 | 671.81 Mn |
| Mar 30, 2025 | 648.19 Mn |
| Dec 29, 2024 | 653.10 Mn |
| Sep 29, 2024 | 687.94 Mn |
| Jun 30, 2024 | 1.39 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 1.45 Bn |
| Oct 1, 2023 | 1.45 Bn |
| Jul 2, 2023 | 1.37 Bn |
| Apr 2, 2023 | 1.56 Bn |
| Jan 1, 2023 | 1.54 Bn |
| Oct 2, 2022 | 1.49 Bn |
| Jul 3, 2022 | 1.04 Bn |
| Apr 3, 2022 | 1.26 Bn |
| Jan 2, 2022 | 1.21 Bn |
| Oct 3, 2021 | 1.15 Bn |
| Jul 4, 2021 | 1.12 Bn |